These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 2005585

  • 1. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, King LW, Miyano M, Gorczynski RJ, Williams MH, Zupec ME, Tjoeng FS.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y, Sato K, Shigenaga T, Hisamichi N, Ichihara M, Akamatsu S, Suzuki Ki, Nii T, Kaku S, Kawasaki T, Matsumoto Y, Inagaki O, Tomioka K, Yanagisawa I.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):43-52. PubMed ID: 11937091
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function.
    Weiss DJ, Evanson OA, Wells RE.
    Am J Vet Res; 1997 May 29; 58(5):457-60. PubMed ID: 9140550
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH.
    J Cardiovasc Pharmacol; 1997 Aug 29; 30(2):261-72. PubMed ID: 9269956
    [Abstract] [Full Text] [Related]

  • 5. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
    Barre DE.
    Thromb Res; 2007 Aug 29; 119(5):601-7. PubMed ID: 16860375
    [Abstract] [Full Text] [Related]

  • 6. SC-49992--a potent and specific inhibitor of platelet aggregation.
    Nicholson NS, Panzer-Knodle SG, King LW, Taite BB, Keller BT, Tjoeng FS, Engleman VW, Giorgio TD, Feigen LP.
    Thromb Res; 1994 Jun 01; 74(5):523-35. PubMed ID: 8085253
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent.
    Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, King LW, Miyano M, Gorczynski RJ, Williams MH, Zupec ME, Tjoeng FS.
    Thromb Res; 1991 Jun 01; 62(5):567-78. PubMed ID: 1896969
    [Abstract] [Full Text] [Related]

  • 8. A mimetic of the RGDF-peptide [arginine-glycine-aspartic acid-phenylalanine] blocks aggregation and flow-induced platelet deposition on severely injured stenotic arterial wall. Effects on different animal models and in humans.
    Pueyo C, Badimon JJ, Royo T, Feigen LP, Badimon L.
    Thromb Res; 1996 Jan 01; 81(1):101-12. PubMed ID: 8747525
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N.
    Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596
    [Abstract] [Full Text] [Related]

  • 10. Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregation.
    Panzer-Knodle S, Taite BB, Mehrotra DV, Nicholson NS, Feigen LP.
    J Pharmacol Toxicol Methods; 1993 Sep 20; 30(1):47-53. PubMed ID: 8241546
    [Abstract] [Full Text] [Related]

  • 11. New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts.
    Rubin BG, McGraw DJ, Sicard GA, Santoro SA.
    J Vasc Surg; 1992 Apr 20; 15(4):683-91; discussion 691-2. PubMed ID: 1560559
    [Abstract] [Full Text] [Related]

  • 12. The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403.
    Katada J, Takiguchi Y, Muramatsu M, Fujiyoshi T, Uno I.
    Thromb Res; 1997 Oct 01; 88(1):27-40. PubMed ID: 9336871
    [Abstract] [Full Text] [Related]

  • 13. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML, Packham MA, Taylor DM, Yeo EL, Gemmell CH, Patil S, Lam SC.
    Thromb Haemost; 1999 Dec 01; 82(6):1680-6. PubMed ID: 10613655
    [Abstract] [Full Text] [Related]

  • 14. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
    Mohri H, Ohkubo T.
    Thromb Haemost; 1993 May 03; 69(5):490-5. PubMed ID: 8322271
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK.
    Circulation; 1994 Jan 03; 89(1):3-12. PubMed ID: 8281661
    [Abstract] [Full Text] [Related]

  • 16. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG.
    Arch Biochem Biophys; 1996 Sep 15; 333(2):407-13. PubMed ID: 8809080
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.